SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Pediatric Endocrinology
Metabolic-Associated Steatotic Liver Disease in Children and Adolescents: A Scoping Review and Narrative Synthesis of Epidemiology, Risk Factors, and Screening Approaches with Emerging Implications for Sub-Saharan Africa
Bruno Basil
Peace Ngozi Okoro
David Umahi Federal University of Health Sciences, Uburu, Nigeria
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: Metabolic-Associated Steatotic Liver Disease (MASLD) is recognized as one of the most common chronic liver diseases in children globally, rising in tandem with the childhood obesity pandemic. Although high-income countries focus on advanced phenotyping, Sub-Saharan Africa (SSA) faces a distinct "two-speed" epidemic characterized by rapid urbanization and a unique "double burden" of malnutrition and obesity. This review examines the global and regional epidemiology of paediatric MASLD, contrasting established Western practices with the unique genetic, environmental, and diagnostic challenges of SSA. Methods: A scoping review was conducted following the PRISMA-ScR guidelines and using the JBI methodological framework. PubMed/MEDLINE, Embase, and African Journals Online (AJOL) were searched for literature published between 2010 and 2025 focusing on epidemiology, risk factors, and diagnostic performance in children aged 0–19 years. Evidence was synthesized to compare global prevalence patterns with emerging African data and to evaluate the validity of conventional screening approaches in resource-limited settings. Results: A total of 68 studies were included. Global evidence estimates paediatric MASLD prevalence between 7.6% and 14% in the general population and as high as 41% among children with obesity. In SSA, data remain sparse but alarming, with pooled prevalence among overweight children reaching 31.1%, a figure derived mostly from studies in the NAFLD-era utilizing ultrasound or ALT proxies, which may not align perfectly with newer MASLD criteria. The region exhibits a distinct "African Paradox" with a lower frequency of the PNPLA3 genetic risk variant (13.7%), which contributes to lower hepatic steatosis on imaging despite pronounced insulin resistance. As a result, reliance on alanine aminotransferase (ALT) and ultrasonography for screening risks under-detection, obscuring the metabolically high-risk yet hepatically lean phenotype common in SSA. Furthermore, environmental drivers such as high-fructose diets and endocrine-disrupting chemicals may be modulating genetic protection. Conclusion: Paediatric MASLD in SSA reflects a multifactorial pathology likely driven by environmental stressors, epigenetic "thrifty phenotype" programming, and rapid nutritional transition rather than simple caloric excess. Western-calibrated diagnostic algorithms
Summary
Keywords
African paradox, Double burden of malnutrition, Epidemiology, Paediatric MASLD, sub-Saharan Africa, Waist-to-height ratio
Received
10 January 2026
Accepted
20 February 2026
Copyright
© 2026 Basil and Okoro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bruno Basil
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.